Novartis Investigative Site is a clinical research site located in Hartford, Connecticut, United States 06102.
Crixeo Clinical Trials Trust Score: 20/100 (FAILING). This profile has not yet been claimed by the site owner.
Novartis Investigative Site has participated in 17 clinical trials with 1 currently active.
Therapeutic areas: Pseudomonas Aeruginosa in Cystic Fibrosis, Acute Heart Failure, Multiple Sclerosis.
Sponsors: Mylan Inc., Novartis Pharmaceuticals, Novartis.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Connecticut · View every site in Hartford
Trust Score: 20/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Novartis Investigative Site has a Crixeo Trust Score of 20/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Novartis Investigative Site has 17 clinical trials on record, with 1 currently active. Their work covers Pseudomonas Aeruginosa in Cystic Fibrosis, Acute Heart Failure, Multiple Sclerosis.
Novartis Investigative Site has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.